Nasal vaccine additive improves flu survival in mice even 100 days after treatment

The COVID-19 pandemic highlighted the need for quick protection against new respiratory viruses. A nasal vaccine additive improved flu survival in mice even 100 days after treatment, suggesting a potential way to temporarily boost natural defenses.